| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2727 | 2018 |
| Molecular determinants of response to anti–programmed cell death (PD)-1 and anti–programmed death-ligand 1 (PD-L1) blockade in patients with non–small-cell lung cancer profiled … H Rizvi, F Sanchez-Vega, K La, W Chatila, P Jonsson, D Halpenny, ... Journal of clinical oncology 36 (7), 633-641, 2018 | 1294 | 2018 |
| The long tail of oncogenic drivers in prostate cancer J Armenia, SAM Wankowicz, D Liu, J Gao, R Kundra, E Reznik, ... Nature genetics 50 (5), 645-651, 2018 | 794 | 2018 |
| Clinical sequencing defines the genomic landscape of metastatic colorectal cancer R Yaeger, WK Chatila, MD Lipsyc, JF Hechtman, A Cercek, ... Cancer cell 33 (1), 125-136. e3, 2018 | 742 | 2018 |
| Genome doubling shapes the evolution and prognosis of advanced cancers CM Bielski, A Zehir, AV Penson, MTA Donoghue, W Chatila, J Armenia, ... Nature genetics 50 (8), 1189-1195, 2018 | 552 | 2018 |
| Comparative molecular analysis of gastrointestinal adenocarcinomas Y Liu, NS Sethi, T Hinoue, BG Schneider, AD Cherniack, F Sanchez-Vega, ... Cancer cell 33 (4), 721-735. e8, 2018 | 519 | 2018 |
| Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients B Nguyen, C Fong, A Luthra, SA Smith, RG DiNatale, S Nandakumar, ... Cell 185 (3), 563-575. e11, 2022 | 387 | 2022 |
| Genetic predictors of response to systemic therapy in esophagogastric cancer YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, ... Cancer discovery, CD-17-0787, 2017 | 339 | 2017 |
| First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial YY Janjigian, SB Maron, WK Chatila, B Millang, SS Chavan, C Alterman, ... The Lancet Oncology 21 (6), 821-831, 2020 | 326 | 2020 |
| Metastasis and immune evasion from extracellular cGAMP hydrolysis J Li, MA Duran, N Dhanota, WK Chatila, SE Bettigole, J Kwon, RK Sriram, ... Cancer discovery 11 (5), 1212-1227, 2021 | 211 | 2021 |
| Machine learning detects pan-cancer ras pathway activation in the cancer genome atlas GP Way, F Sanchez-Vega, K La, J Armenia, WK Chatila, A Luna, ... Cell reports 23 (1), 172-180. e3, 2018 | 162 | 2018 |
| A comprehensive comparison of early-onset and average-onset colorectal cancers A Cercek, WK Chatila, R Yaeger, H Walch, GDS Fernandes, A Krishnan, ... JNCI: Journal of the National Cancer Institute 113 (12), 1683-1692, 2021 | 130 | 2021 |
| Clinical and molecular predictors of response to immune checkpoint inhibitors in patients with advanced esophagogastric cancer M Greally, JF Chou, WK Chatila, M Margolis, M Capanu, JF Hechtman, ... Clinical cancer research 25 (20), 6160-6169, 2019 | 92 | 2019 |
| Comparison of optomotor and optokinetic reflexes in mice F Kretschmer, M Tariq, W Chatila, B Wu, TC Badea Journal of Neurophysiology 118 (1), 300-316, 2017 | 88 | 2017 |
| Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer WK Chatila, JK Kim, H Walch, MR Marco, CT Chen, F Wu, DM Omer, ... Nature medicine 28 (8), 1646-1655, 2022 | 79 | 2022 |
| Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA AN Gorelick, M Kim, WK Chatila, K La, AA Hakimi, MF Berger, BS Taylor, ... Nature metabolism 3 (4), 558-570, 2021 | 73 | 2021 |
| Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer J Datta, JJ Smith, WK Chatila, JC McAuliffe, C Kandoth, E Vakiani, ... Clinical Cancer Research 26 (5), 1077-1085, 2020 | 73 | 2020 |
| Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis J Vedanayagam, WK Chatila, BA Aksoy, S Majumdar, AJ Skanderup, ... Nature communications 10 (1), 3682, 2019 | 64 | 2019 |
| Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas AN Shoushtari, WK Chatila, A Arora, F Sanchez-Vega, HS Kantheti, ... Clinical Cancer Research 27 (8), 2226-2235, 2021 | 40 | 2021 |
| Specific mutations in APC, but not alterations in DNA damage response, associate with outcomes of patients with metastatic colorectal cancer S Mondaca, H Walch, S Nandakumar, WK Chatila, N Schultz, R Yaeger Gastroenterology 159 (5), 1975-1978. e4, 2020 | 37 | 2020 |
Nikolaus SchultzCenter for Molecular Oncology, Memorial Sloan Kettering Cancer Centercbio.mskcc.org의 이메일 확인됨